Abstract
Iron-oxide-containing double emulsion capsules carrying both hydrophilic and hydrophobic therapeutic molecules can deliver drugs and energy on demand in vivo. Magneto-chemotherapy/hyperthermia involves a burst-like release of hydrophilic doxorubicin and hydrophobic paclitaxel, remotely triggered by a high frequency magnetic field, which also releases energy via internalized iron oxide nanoparticles, all contributing to cell kill.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents / administration & dosage*
-
Cell Line, Tumor
-
Doxorubicin / administration & dosage
-
Emulsions / chemistry
-
Ferric Compounds / chemistry
-
HeLa Cells
-
Humans
-
Hydrophobic and Hydrophilic Interactions
-
Hyperthermia, Induced
-
Magnetic Fields
-
Mice
-
Nanocapsules / chemistry*
-
Nanoparticles / chemistry*
-
Neoplasms / drug therapy*
-
Paclitaxel / administration & dosage
-
Polymers / chemistry*
-
Transplantation, Heterologous
Substances
-
Antineoplastic Agents
-
Emulsions
-
Ferric Compounds
-
Nanocapsules
-
Polymers
-
ferric oxide
-
Doxorubicin
-
Paclitaxel